Today

Agents

Chat

Arena

Discover

More

App

Zentalis Pharmaceuticals Announces Pricing Of Underwritten Public Offering - ZNTL News | Rallies

Zentalis Pharmaceuticals Announces Pricing Of Underwritten Public Offering

ZNTL•2026-08-14

Public offering priced at $3.50 a share

Aug. 13 (Reuters) - Zentalis Pharmaceuticals Inc. ZNTL.O:

Zentalis Pharmaceuticals announces pricing of underwritten public offering
Zentalis Pharmaceuticals prices public offering of 23 million shares at $3.50 per share

Further company coverage: ZNTL.O

Related News

Tapestry, Inc. <TPR.N>: BTIG Cuts Target Price to $175 from $180

TPR•2026-08-14

Texas Roadhouse director Gregory N. Moore disposes of 3,000 common shares worth $624,960

TXRH•2026-08-14

PRESS DIGEST-Financial Times - August 14

2026-08-14

Arcutis EVP, Chief Medical Officer Patrick Burnett disposes of USD 392,075.19 in common shares

ARQT•2026-08-14

Honeywell Technologies <HON.O>: JP Morgan Cuts Target Price to $255 From $262

HON•2026-08-14